Search

everythinglearnresearchcommunity

for

Search:↓

Mesenchymal stem cell therapy may help treat alopecia areata by promoting hair growth and reducing inflammation.

Skin problems are common after stem cell transplants, and early treatment by dermatologists can improve patient outcomes.

MSC-Exos can aid organ development and offer therapeutic benefits for various conditions.

Hair loss in Androgenetic alopecia (AGA) is due to altered cell sensitivity to hormones, not increased hormone levels. Hair growth periods shorten over time, causing hair to become thinner and shorter. This is linked to miscommunication between cell pathways in hair follicles. There's also a change in gene expression related to blood vessels and cell growth in balding hair follicles. The exact molecular causes of AGA are still unclear.

Skin healing from blisters can delay hair growth as stem cells focus on repairing skin over developing hair.

Calcium signals and SHH guide the direction of feather growth in chicken skin.

Blocking IL-12/IL-23p40 helped reverse severe hair loss in patients.

Fat from the body can help improve hair growth and scars when used in skin treatments.

Lymphatic vessels are essential for hair follicle growth and skin regeneration.

ADSC-CE treatment safely increases hair density and thickness in androgenetic alopecia patients.

The secretome from mesenchymal stem cells is a promising treatment that may repair tissue and avoid side effects of stem cell transplantation.

Macrophages help regrow hair by activating stem cells using AKT/β-catenin and TNF.

The visfatin GT genotype may increase the risk of Alopecia Areata.

Drosha and Dicer are essential for hair follicle health and preventing DNA damage in skin cells.

A woman with alopecia totalis regrew dark hair in bands after using a corticosteroid ointment.

Calreticulin has roles in healing, immune response, and disease beyond its known functions in the endoplasmic reticulum.

A woman with alopecia regrew her hair after taking a higher dose of tocilizumab.

New findings suggest targeting IL-23 could treat psoriasis, skin cells can adapt to new roles, direct conversion of skin cells to blood cells may aid cell therapy, removing certain tumor cells could boost cancer immunotherapy, and melanoma may have many tumorigenic cells, not just cancer stem cells.

Hair follicle stem cells are a promising source for tissue repair and treating skin or hair diseases.

Advanced therapies like gene, cell, and tissue engineering show promise for hair regrowth in alopecia, but their safety and effectiveness need more verification.

MicroRNAs are crucial in controlling cell signaling, affecting cancer and tissue regeneration.

The conclusion is that we need more effective hair loss treatments than the current ones, and these could include new drugs, gene and stem cell therapy, hormones, and scalp cooling, but they all need thorough safety testing.

Different cell types work together to repair skin, and targeting them may improve healing and reduce scarring.

Genes related to keratin, skin cell differentiation, and immune functions are key in hedgehog skin and spine development.

CD4+ skin cells may be precursors to basal cell carcinoma.

Mice treatments didn't grow hair, a patient treatment may affect immune response, and people with hair loss often feel anxious or depressed.

Antiyeast treatments work better for seborrheic dermatitis than steroids, and other findings include increased skin bacteria under plastic wrap, a nasal cell defect in Staphylococcus aureus carriers, quick resolution of certain skin reactions, high rubber latex allergy in spina bifida patients, and glyceryl monopentadecanoate's effectiveness for male hair loss.

Cyclosporin doesn't stop hair loss.

Exosomes could potentially enhance tissue repair and regeneration with lower rejection risk and easier production than live cell therapies.

Changes to the Foxp3 protein affect how well regulatory T cells can control the immune system, which could help treat immune diseases and cancer.